BOSTON, Aug. 29, 2017 /PRNewswire/ -- Michael Bocchini, a recognized leader in the global life sciences industry is to join DPS as Vice President of Operations, where he will play a pivotal role in the expansion of DPS' operations in the United States. In this key role, Mike will report directly to Ger Morgan, President of Operations, Technical Services Organisation (TSO).
Michael Bocchini is an industry veteran with more than 25 years of biotech, pharmaceutical and chemical industry experience. Previously he worked with Jacobs Engineering Life Sciences Division where for the past 10 years he has lead that company's Commissioning, Qualification and Validation functions. With Jacobs, he was responsible for overall global operations and P&L supporting pharmaceutical, biotech and medical service companies, conducting business in the USA, European and Asia Pacific markets.
Commenting on the appointment, DPS President of Operations for TSO, Ger Morgan said: "Mike Bocchini has a very successful track record in running and growing businesses directly relevant to the sectors in which DPS operates. As VP of Operations, he will play a key role in the expansion of our business both through organic development and acquisition."
Mike Bocchini commented: "I have been very impressed with how DPS has developed a substantial and successful business in the United States. I have been particularly impressed with their focus on clients and their overall strategic growth plan and I look forward to contributing to further growth in the years ahead."
DPS is a leading engineering and construction firm with a focus on the life sciences and semiconductor sectors. DPS delivers services for clients across the complete engineering and construction value chain including feasibility studies, concepts, architecture, engineering, procurement, construction management, commissioning, qualification and validation.
DPS applies its extensive Process Engineering expertise built over 40+years, as well as significant Lean Construction experience to assist our clients in high-end process sectors such as pharmaceuticals, biotech, medical devices and semiconductors deliver their manufacturing facilities speedily, safely and cost effectively. What sets us apart are the partnerships we build with our clients through a fundamental understanding of their businesses and our own agility, flexibility, original thinking and our high-calibre people.
We have grown substantially in recent years and now employ over 1,200 people in our offices and on client sites in Ireland, Netherlands, Belgium, Israel, Singapore and the United States. For more information, visit www.dpsgroupglobal.com.
Annette O'Hara, Group Marketing Manager
E [email protected]
SOURCE DPS Engineering